211 related articles for article (PubMed ID: 9586892)
1. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.
Riethmüller G; Holz E; Schlimok G; Schmiegel W; Raab R; Höffken K; Gruber R; Funke I; Pichlmaier H; Hirche H; Buggisch P; Witte J; Pichlmayr R
J Clin Oncol; 1998 May; 16(5):1788-94. PubMed ID: 9586892
[TBL] [Abstract][Full Text] [Related]
2. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group.
Riethmüller G; Schneider-Gädicke E; Schlimok G; Schmiegel W; Raab R; Höffken K; Gruber R; Pichlmaier H; Hirche H; Pichlmayr R
Lancet; 1994 May; 343(8907):1177-83. PubMed ID: 7909866
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
6. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
[TBL] [Abstract][Full Text] [Related]
7. Estimation of the number of metastatic lymph nodes in dukes' C colorectal cancer.
Fukushima T; Akagi Y; Murakami H; Ushijima M; Ogata Y; Shirouzu K; Murotani K
Anticancer Res; 2013 Jul; 33(7):2949-55. PubMed ID: 23780985
[TBL] [Abstract][Full Text] [Related]
8. Factors predictive of survival in patients with node-positive colorectal cancer in Taiwan.
Wang WS; Chen PM; Chiou TJ; Liu JH; Fan FS; Lin TC; Jiang JK; Yang SH; Yen CC; Wang HS; Lin JK
Hepatogastroenterology; 2000; 47(36):1590-4. PubMed ID: 11149009
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma.
Diez M; Cerdán FJ; Pollán M; Maestro ML; Ortega MD; Martínez S; Moreno G; Balibrea JL
Anticancer Res; 1994; 14(6B):2819-25. PubMed ID: 7872725
[TBL] [Abstract][Full Text] [Related]
10. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
[TBL] [Abstract][Full Text] [Related]
11. Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients.
Mulder WM; Stern PL; Stukart MJ; de Windt E; Butzelaar RM; Meijer S; Adér HJ; Claessen AM; Vermorken JB; Meijer CJ; Wagstaff J; Scheper RJ; Bloemena E
Clin Cancer Res; 1997 Nov; 3(11):1923-30. PubMed ID: 9815581
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer.
Ayude D; Páez De La Cadena M; Martínez-Zorzano VS; Fernández-Briera A; Rodríguez-Berrocal FJ
Oncology; 2003; 64(1):36-45. PubMed ID: 12457030
[TBL] [Abstract][Full Text] [Related]
13. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
[TBL] [Abstract][Full Text] [Related]
14. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
15. Site and Stage of Colorectal Cancer Influence the Likelihood and Distribution of Disease Recurrence and Postrecurrence Survival: Data From the FACS Randomized Controlled Trial.
Pugh SA; Shinkins B; Fuller A; Mellor J; Mant D; Primrose JN
Ann Surg; 2016 Jun; 263(6):1143-7. PubMed ID: 26135689
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer.
Miyamoto Y; Baba Y; Sakamoto Y; Ohuchi M; Tokunaga R; Kurashige J; Hiyoshi Y; Iwagami S; Yoshida N; Yoshida M; Watanabe M; Baba H
Ann Surg Oncol; 2015 Aug; 22(8):2663-8. PubMed ID: 25564158
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer.
Ropponen K; Tammi M; Parkkinen J; Eskelinen M; Tammi R; Lipponen P; Agren U; Alhava E; Kosma VM
Cancer Res; 1998 Jan; 58(2):342-7. PubMed ID: 9443415
[TBL] [Abstract][Full Text] [Related]
18. Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
Foon KA; John WJ; Chakraborty M; Das R; Teitelbaum A; Garrison J; Kashala O; Chatterjee SK; Bhattacharya-Chatterjee M
J Clin Oncol; 1999 Sep; 17(9):2889-5. PubMed ID: 10561367
[TBL] [Abstract][Full Text] [Related]
19. Surgery for lung metastases from colorectal cancer: analysis of prognostic factors.
Girard P; Ducreux M; Baldeyrou P; Rougier P; Le Chevalier T; Bougaran J; Lasser P; Gayet B; Ruffié P; Grunenwald D
J Clin Oncol; 1996 Jul; 14(7):2047-53. PubMed ID: 8683235
[TBL] [Abstract][Full Text] [Related]
20. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.
Evans MD; Barton K; Rees A; Stamatakis JD; Karandikar SS
Colorectal Dis; 2008 Feb; 10(2):157-64. PubMed ID: 17477849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]